Condition: Infection · Sponsor: Balgrist University Hospital
We implement a prospective, randomized, unblinded, non-inferiority trial regarding the duration of systemic, targeted antibiotic therapy after the first surgical debridement for spine infection; randomizing 1:1 between 1. Six and twelve weeks of antibiotic therapy if there is an implant left in place 2. Three and six weeks of antibiotic therapy if there is no implant left
This description comes directly from the study's public registry record.
Ilker Uckay, PD Dr med · +41 44 386 1111 · ilker.uckay@balgrist.ch
Michael Betz, PD Dr med · +41 44 386 1111 · michael.betz@balgrist.ch
Always discuss trial participation with your own doctor first.
| Balgrist University Hospital | Zurich, Canton of Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04048304